Source:http://linkedlifedata.com/resource/pubmed/id/20205259
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2010-3-15
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1545-5017
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
54
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
781-2
|
| pubmed:meshHeading |
pubmed-meshheading:20205259-Antimetabolites, Antineoplastic,
pubmed-meshheading:20205259-Child, Preschool,
pubmed-meshheading:20205259-Cytidine Deaminase,
pubmed-meshheading:20205259-Deoxycytidine,
pubmed-meshheading:20205259-Female,
pubmed-meshheading:20205259-Humans,
pubmed-meshheading:20205259-Neuroblastoma,
pubmed-meshheading:20205259-Tumor Lysis Syndrome
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?
|
| pubmed:publicationType |
Letter,
Case Reports
|